226 related articles for article (PubMed ID: 24077288)
1. Antibody-directed coupling of endoglin and MMP-14 is a key mechanism for endoglin shedding and deregulation of TGF-β signaling.
Kumar S; Pan CC; Bloodworth JC; Nixon AB; Theuer C; Hoyt DG; Lee NY
Oncogene; 2014 Jul; 33(30):3970-9. PubMed ID: 24077288
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis.
Hawinkels LJ; Kuiper P; Wiercinska E; Verspaget HW; Liu Z; Pardali E; Sier CF; ten Dijke P
Cancer Res; 2010 May; 70(10):4141-50. PubMed ID: 20424116
[TBL] [Abstract][Full Text] [Related]
3. Soluble MMP-14 produced by bone marrow-derived stromal cells sheds epithelial endoglin modulating the migratory properties of human breast cancer cells.
Tobar N; Avalos MC; Méndez N; Smith PC; Bernabeu C; Quintanilla M; Martínez J
Carcinogenesis; 2014 Aug; 35(8):1770-9. PubMed ID: 24618373
[TBL] [Abstract][Full Text] [Related]
4. Effects of the combination of TRC105 and bevacizumab on endothelial cell biology.
Liu Y; Tian H; Blobe GC; Theuer CP; Hurwitz HI; Nixon AB
Invest New Drugs; 2014 Oct; 32(5):851-9. PubMed ID: 24994097
[TBL] [Abstract][Full Text] [Related]
5. Endoglin requirement for BMP9 signaling in endothelial cells reveals new mechanism of action for selective anti-endoglin antibodies.
Nolan-Stevaux O; Zhong W; Culp S; Shaffer K; Hoover J; Wickramasinghe D; Ruefli-Brasse A
PLoS One; 2012; 7(12):e50920. PubMed ID: 23300529
[TBL] [Abstract][Full Text] [Related]
6. Regulation of TGF-β receptor hetero-oligomerization and signaling by endoglin.
Pomeraniec L; Hector-Greene M; Ehrlich M; Blobe GC; Henis YI
Mol Biol Cell; 2015 Sep; 26(17):3117-27. PubMed ID: 26157163
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
Takahashi N; Haba A; Matsuno F; Seon BK
Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
[TBL] [Abstract][Full Text] [Related]
8. The interaction of endoglin with beta-arrestin2 regulates transforming growth factor-beta-mediated ERK activation and migration in endothelial cells.
Lee NY; Blobe GC
J Biol Chem; 2007 Jul; 282(29):21507-17. PubMed ID: 17540773
[TBL] [Abstract][Full Text] [Related]
9. Endoglin promotes transforming growth factor beta-mediated Smad 1/5/8 signaling and inhibits endothelial cell migration through its association with GIPC.
Lee NY; Ray B; How T; Blobe GC
J Biol Chem; 2008 Nov; 283(47):32527-33. PubMed ID: 18775991
[TBL] [Abstract][Full Text] [Related]
10. Endoglin regulates PI3-kinase/Akt trafficking and signaling to alter endothelial capillary stability during angiogenesis.
Lee NY; Golzio C; Gatza CE; Sharma A; Katsanis N; Blobe GC
Mol Biol Cell; 2012 Jul; 23(13):2412-23. PubMed ID: 22593212
[TBL] [Abstract][Full Text] [Related]
11. Expression and functional analysis of endoglin in isolated liver cells and its involvement in fibrogenic Smad signalling.
Meurer SK; Tihaa L; Borkham-Kamphorst E; Weiskirchen R
Cell Signal; 2011 Apr; 23(4):683-99. PubMed ID: 21146604
[TBL] [Abstract][Full Text] [Related]
12. ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration.
Ray BN; Lee NY; How T; Blobe GC
Carcinogenesis; 2010 Mar; 31(3):435-41. PubMed ID: 20042635
[TBL] [Abstract][Full Text] [Related]
13. Endoglin targeting inhibits tumor angiogenesis and metastatic spread in breast cancer.
Paauwe M; Heijkants RC; Oudt CH; van Pelt GW; Cui C; Theuer CP; Hardwick JC; Sier CF; Hawinkels LJ
Oncogene; 2016 Aug; 35(31):4069-79. PubMed ID: 26804178
[TBL] [Abstract][Full Text] [Related]
14. Toxicarioside A inhibits tumor growth and angiogenesis: involvement of TGF-β/endoglin signaling.
Huang FY; Mei WL; Li YN; Tan GH; Dai HF; Guo JL; Wang H; Huang YH; Zhao HG; Zhou SL; Lin YY
PLoS One; 2012; 7(11):e50351. PubMed ID: 23209720
[TBL] [Abstract][Full Text] [Related]
15. Coculture with prostate cancer cells alters endoglin expression and attenuates transforming growth factor-beta signaling in reactive bone marrow stromal cells.
O'Connor JC; Farach-Carson MC; Schneider CJ; Carson DD
Mol Cancer Res; 2007 Jun; 5(6):585-603. PubMed ID: 17579118
[TBL] [Abstract][Full Text] [Related]
16. Src-mediated post-translational regulation of endoglin stability and function is critical for angiogenesis.
Pan CC; Kumar S; Shah N; Hoyt DG; Hawinkels LJ; Mythreye K; Lee NY
J Biol Chem; 2014 Sep; 289(37):25486-96. PubMed ID: 25070888
[TBL] [Abstract][Full Text] [Related]
17. Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer.
Liu Y; Starr MD; Brady JC; Dellinger A; Pang H; Adams B; Theuer CP; Lee NY; Hurwitz HI; Nixon AB
Cancer Med; 2014 Jun; 3(3):580-91. PubMed ID: 24574330
[TBL] [Abstract][Full Text] [Related]
18. Endoglin differentially regulates TGF-β-induced Smad2/3 and Smad1/5 signalling and its expression correlates with extracellular matrix production and cellular differentiation state in human chondrocytes.
Finnson KW; Parker WL; Chi Y; Hoemann CD; Goldring MB; Antoniou J; Philip A
Osteoarthritis Cartilage; 2010 Nov; 18(11):1518-27. PubMed ID: 20833252
[TBL] [Abstract][Full Text] [Related]
19. EPDR1 is a noncanonical effector of insulin-mediated angiogenesis regulated by an endothelial-specific TGF-β receptor complex.
Ahmed T; Flores PC; Pan CC; Ortiz HR; Lee YS; Langlais PR; Mythreye K; Lee NY
J Biol Chem; 2022 Sep; 298(9):102297. PubMed ID: 35872017
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin-3-gallate inhibits tumor angiogenesis: involvement of endoglin/Smad1 signaling in human umbilical vein endothelium cells.
Chen CY; Lin YJ; Wang CCN; Lan YH; Lan SJ; Sheu MJ
Biomed Pharmacother; 2019 Dec; 120():109491. PubMed ID: 31586903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
